Source: MarketScreener

Deep Genomics: Deep Genomics to Present at the 40th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) Deep Genomics, the leading AI RNA therapeutics company, today announced that its Founder and CEO, Brendan Frey, PhD, FRSC, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10:00 a.m. EST. The presentation will be available as a live webcast through the J.P. Morgan Healthcare Conference...https://www.marketscreener.com/news/latest/Deep-Genomics-to-Present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference--37482166/?utm_medium=RSS&utm_content=20220106

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Brian O’Callaghan's photo - CEO of Deep Genomics

CEO

Brian O’Callaghan

CEO Approval Rating

82/100

Read more